Groundbreaking COVID-19 Blood Donor Seroprevalence Study Illustrates Increase in Population with Antibodies Because of Vaccination
More than 1.5 million samples from blood donations were tested over 11 months, estimating an 83.3% rate for combined infection- and vaccine-induced antibodies, among other observations.
- More than 1.5 million samples from blood donations were tested over 11 months, estimating an 83.3% rate for combined infection- and vaccine-induced antibodies, among other observations.
- The regions covered by the MASS-BD program represent 74% of the U.S. population greater than 16 years old.
- "The act of donating blood not only helps save lives every day, but it is also providing critical research data to track the pandemic."
- Those who receive Food and Drug Administration approved or authorized vaccines are eligible to give blood providing they meet other eligibility requirements.